Monthly
US$200
Billed every month
Metformin Hydrochloride Extended-release Tablets(盐酸二甲双胍缓释片)
Companies, stages and changes, with each record available on this page.
Last 90 days: Accepted: 5 applicationsNo longer listed under review: 2 applicationsSupplement delivery: 1 applicationApproval-document delivery record: 1 application
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Company names, approval identifiers and strengths are retained as recorded in the Chinese sources. Category labels include the original wording for verification.
Catalogue holders50View records ↓
Under-review filings10View records ↓
This year’s generic filers2View records ↓
NHSA approval numbers71View records ↓
API companies with A status40View records ↓
Chemical-drug catalogue
Loaded records: 50 holders; 26 in the quality-and-efficacy consistency-evaluation category, and 23 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| 石家庄市华新药业有限责任公司 | 石家庄市华新药业有限责任公司 | 国药准字H20269141 | 2026/06/25 | 0.75g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 石家庄市华新药业有限责任公司 | 石家庄市华新药业有限责任公司 | 国药准字H20269142 | 2026/06/25 | 1.0g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 山东济坤生物制药有限公司 | 寿光富康制药有限公司 | 国药准字H20264921 | 2026/06/23 | 0.75g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东济坤生物制药有限公司 | 寿光富康制药有限公司 | 国药准字H20264920 | 2026/06/23 | 0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江三生蔓迪药业有限公司 | 浙江三生蔓迪药业有限公司 | 国药准字H20080103 | 2026/03/25 | 0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 石家庄市普力制药有限公司 | 石家庄市普力制药有限公司 | 国药准字H20256230 | 2025/12/09 | 0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 石家庄市普力制药有限公司 | 石家庄市普力制药有限公司 | 国药准字H20256231 | 2025/12/09 | 0.75g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 石家庄市普力制药有限公司 | 石家庄市普力制药有限公司 | 国药准字H20256232 | 2025/12/09 | 1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江众延医药科技有限公司 | 石家庄市华新药业有限责任公司 | 国药准字H20254325 | 2025/05/27 | 0.75g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 重庆药友制药有限责任公司 | 重庆药友制药有限责任公司 | 国药准字H20253450 | 2025/02/25 | 0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山西同达药业有限公司 | 山西同达药业有限公司 | 国药准字H20100173 | 2024/10/12 | 0.5g（以盐酸二甲双胍计） | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 山东汇泽生物制药有限公司 | 地奥集团成都药业股份有限公司 | 国药准字H20244835 | 2024/09/10 | 0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江众延医药科技有限公司 | 石家庄市华新药业有限责任公司 | 国药准字H20244548 | 2024/07/30 | 1.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 河南羚锐制药股份有限公司 | 河南羚锐制药股份有限公司 | 国药准字H20243635 | 2024/04/30 | 500mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江京新药业股份有限公司 | 浙江京新药业股份有限公司 | 国药准字H20243541 | 2024/04/17 | 0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 北京京丰制药（山东）有限公司 | 北京京丰制药（山东）有限公司 | 国药准字H20051187 | 2023/08/26 | 0.5g(以盐酸二甲双胍计) | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 青岛黄海生物制药有限责任公司 | 青岛黄海制药有限责任公司 | 国药准字H20234038 | 2023/08/08 | 0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 辽宁奥达制药有限公司 | 辽宁奥达制药有限公司 | 国药准字H20070117 | 2023/07/06 | 0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 江苏德源药业股份有限公司 | 江苏德源药业股份有限公司 | 国药准字H20237050 | 2023/05/08 | 0.75g(以盐酸二甲双胍计) | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 哈尔滨珍宝制药有限公司 | 哈尔滨珍宝制药有限公司 | 国药准字H20233284 | 2023/03/21 | 0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 北京元延医药科技股份有限公司 | 乐声药业石家庄有限公司 | 国药准字H20233061 | 2023/01/19 | 0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 重庆科瑞南海制药有限责任公司 | 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 2022/11/10 | 0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 寿光富康制药有限公司 | 寿光富康制药有限公司 | 国药准字H20223796 | 2022/11/01 | 0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 盖天力医药控股集团制药股份有限公司 | 盖天力医药控股集团制药股份有限公司 | 国药准字H20223774 | 2022/10/25 | 0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东司邦得制药有限公司 | 山东司邦得制药有限公司 | 国药准字H20060230 | 2022/09/16 | 0.5g(以盐酸二甲双胍计) | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 南京瑞捷医药科技有限公司 | 浙江杭康药业有限公司 | 国药准字H20223245 | 2022/04/19 | 0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东新时代药业有限公司 | 山东新时代药业有限公司 | 国药准字H20223229 | 2022/04/12 | 0.5g（以盐酸二甲双胍计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 河南福森药业有限公司 | 河南福森药业有限公司 | 国药准字H20080279 | 2022/04/12 | 0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 海南海力制药有限公司 | 海南海力制药有限公司 | 国药准字H20050070 | 2022/04/12 | 0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 南昌市飞弘药业有限公司 | 南昌市飞弘药业有限公司 | 国药准字H20051662 | 2022/04/12 | 0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 河北山姆士药业有限公司 | 河北山姆士药业有限公司 | 国药准字H20123024 | 2021/08/12 | 0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 辰欣药业股份有限公司 | 辰欣药业股份有限公司 | 国药准字H20213623 | 2021/07/28 | 0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 成都倍特药业股份有限公司 | 成都倍特药业股份有限公司 | 国药准字H20213488 | 2021/06/16 | 0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 海南普利制药股份有限公司 | 海南普利制药股份有限公司 | 国药准字H20040971 | 2021/05/06 | 0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 上海普康药业有限公司 | 上海普康药业有限公司 | 国药准字H20050052 | 2021/05/06 | 0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 山东明仁福瑞达制药股份有限公司 | 山东明仁福瑞达制药股份有限公司 | 国药准字H20052118 | 2021/05/06 | 0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 山东齐都药业有限公司 | 山东齐都药业有限公司 | 国药准字H20050374 | 2020/12/15 | 0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 海南海灵化学制药有限公司 | 海南海灵化学制药有限公司 | 国药准字H20203613 | 2020/11/24 | 0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 宜昌人福药业有限责任公司 | 宜昌人福药业有限责任公司 | 国药准字H20203371 | 2020/07/29 | 500mg（以盐酸二甲双胍片） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 深圳翰宇药业股份有限公司 | 深圳翰宇药业股份有限公司 | 国药准字H20203361 | 2020/07/29 | 0.5g（以盐酸二甲双胍计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 宜昌人福药业有限责任公司 | 宜昌人福药业有限责任公司 | 国药准字H20203312 | 2020/07/16 | 750mg（以盐酸二甲双胍片） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| — | 青岛黄海制药有限责任公司 | 国药准字H20040154 | 2020/04/15 | 0.5g（以盐酸二甲双胍计） | Not stated by source | CDE |
| — | 山东凤凰制药股份有限公司 | 国药准字H20051542 | 2020/03/26 | 0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 山西华元医药生物技术有限公司 | 国药准字H20060815 | 2020/03/24 | 0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 石家庄市华新药业有限责任公司 | 国药准字H20140023 | 2020/02/19 | 0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 美罗药业股份有限公司 | 国药准字H20193282 | 2019/09/26 | 0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| — | 石药集团欧意药业有限公司 | 国药准字H20193270 | 2019/09/17 | 0.75g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| — | 石药集团欧意药业有限公司 | 国药准字H20193269 | 2019/09/17 | 0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 广东赛康制药厂有限公司 | 广东赛康制药厂有限公司 | 国药准字H20178002 | 2019/09/09 | 0.5g（以盐酸二甲双胍计） | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 天方药业有限公司 | 国药准字H20031225 | 2019/07/09 | 0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 正大天晴药业集团股份有限公司 | 正大天晴药业集团股份有限公司 | 国药准字H20031104 | 2019/07/09 | 0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 南京亿华药业有限公司 | 国药准字H20040816 | 2019/06/21 | 0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 北京万辉双鹤药业有限责任公司 | 国药准字H20041986 | 2019/04/15 | 0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 浙江海正宣泰医药有限公司 | 上海宣泰海门药业有限公司 | 国药准字H20193023 | 2019/01/15 | 0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| — | 悦康药业集团有限公司 | 国药准字H20051289 | 2018/12/18 | 0.5g（以C4H11N5·HCl计） | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 上海上药信谊药厂有限公司 | 国药准字H20050699 | 2018/12/07 | 0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 江苏德源药业股份有限公司 | 国药准字H20080252 | 2018/11/13 | 0.5g（以C4H11N5·HCl计） | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| Merck Serono Limited | Merck KGaA | H20170029;H20170030 | 2003/10/08 | 0.5g | Imported originator drug (进口原研药品) | CDE |
| 成都恒瑞制药有限公司 | 成都恒瑞制药有限公司 | 国药准字H20030952 | 2003/09/23 | 0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 71 distinct approval numbers and 64 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| 山东普瑞曼药业有限公司 | 国药准字H20263171 | 0.5g | Category B (乙) | XA10BAE021A010010184621 | NHSA |
| 山东普瑞曼药业有限公司 | 国药准字H20263171 | 0.5g | Category B (乙) | XA10BAE021A010010284621 | NHSA |
| 山东普瑞曼药业有限公司 | 国药准字H20263171 | 0.5g | Category B (乙) | XA10BAE021A010010384621 | NHSA |
| 山东普瑞曼药业有限公司 | 国药准字H20263171 | 0.5g | Category B (乙) | XA10BAE021A010010484621 | NHSA |
| 重庆药友制药有限责任公司 | 国药准字H20253450 | 0.5g | Category B (乙) | XA10BAE021A010010101066 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20256230 | 0.5g | Category B (乙) | XA10BAE021A010010107340 | NHSA |
| 重庆药友制药有限责任公司 | 国药准字H20253450 | 0.5g | Category B (乙) | XA10BAE021A010010201066 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20256230 | 0.5g | Category B (乙) | XA10BAE021A010020107340 | NHSA |
| 浙江众延医药科技有限公司 | 国药准字H20254325 | 0.75g | Category B (乙) | XA10BAE021A010020184225 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20256230 | 0.5g | Category B (乙) | XA10BAE021A010030107340 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20256230 | 0.5g | Category B (乙) | XA10BAE021A010040107340 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20256230 | 0.5g | Category B (乙) | XA10BAE021A010050107340 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20256230 | 0.5g | Category B (乙) | XA10BAE021A010060107340 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20256230 | 0.5g | Category B (乙) | XA10BAE021A010070107340 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20256230 | 0.5g | Category B (乙) | XA10BAE021A010080107340 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20256230 | 0.5g | Category B (乙) | XA10BAE021A010090107340 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20256230 | 0.5g | Category B (乙) | XA10BAE021A010100107340 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20256230 | 0.5g | Category B (乙) | XA10BAE021A010110107340 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20256230 | 0.5g | Category B (乙) | XA10BAE021A010120107340 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20256232 | 1.0g | Category B (乙) | XA10BAE021A010130107340 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20256230 | 0.5g | Category B (乙) | XA10BAE021A010140107340 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20256230 | 0.5g | Category B (乙) | XA10BAE021A010150107340 | NHSA |
| 新石阳光药业(河北)有限公司 | 国药准字H20256230 | 0.5g | Category B (乙) | XA10BAE021A010160107340 | NHSA |
| 北京巨能制药有限责任公司 | 国药准字H20060782 | 0.5g | Category B (乙) | XA10BAE021A010010100068 | NHSA |
| 北京太洋药业股份有限公司 | 国药准字H20090050 | 0.5g | Category B (乙) | XA10BAE021A010010100154 | NHSA |
| 北京万辉双鹤药业有限责任公司 | 国药准字H20041986 | 0.5g | Category B (乙) | XA10BAE021A010010100176 | NHSA |
| 悦康药业集团股份有限公司 | 国药准字H20051289 | 0.5g | Category B (乙) | XA10BAE021A010010100239 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20090120 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010100248 | NHSA |
| 广东隆赋药业股份有限公司 | 国药准字H20041065 | 0.25g | Category B (乙) | XA10BAE021A010010100336 | NHSA |
| 深圳市中联制药有限公司 | 国药准字H20041221 | 0.5g | Category B (乙) | XA10BAE021A010010100543 | NHSA |
| 恒昌(广州)新药研究有限公司 | 国药准字H20050052 | 0.5g | Category B (乙) | XA10BAE021A010010100732 | NHSA |
| 上海上药信谊药厂有限公司 | 国药准字H20050699 | 0.5g | Category B (乙) | XA10BAE021A010010100818 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010010101021 | NHSA |
| 美罗药业股份有限公司 | 国药准字H20193282 | 0.5g | Category B (乙) | XA10BAE021A010010101122 | NHSA |
| 辽宁奥达制药有限公司 | 国药准字H20070117 | 0.5g | Category B (乙) | XA10BAE021A010010101351 | NHSA |
| 山东力诺制药有限公司 | 国药准字H20223774 | 0.5g | Category B (乙) | XA10BAE021A010010101403 | NHSA |
| 苏中药业集团股份有限公司 | 国药准字H20051117 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010101493 | NHSA |
| 江苏祥瑞药业有限公司 | 国药准字H20051653 | 0.5g | Category B (乙) | XA10BAE021A010010101506 | NHSA |
| 正大天晴药业集团股份有限公司 | 国药准字H20031104 | 0.5g | Category B (乙) | XA10BAE021A010010101523 | NHSA |
| 山西同达药业有限公司 | 国药准字H20100173 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010101534 | NHSA |
| 南京亿华药业有限公司 | 国药准字H20040816 | 0.5g | Category B (乙) | XA10BAE021A010010101604 | NHSA |
| 宜昌人福药业有限责任公司 | 国药准字H20203371 | 500mg(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010102000 | NHSA |
| 成都倍特药业股份有限公司 | 国药准字H20213488 | 0.5g | Category B (乙) | XA10BAE021A010010102013 | NHSA |
| 成都恒瑞制药有限公司 | 国药准字H20030952 | 0.5g | Category B (乙) | XA10BAE021A010010102031 | NHSA |
| 石家庄市华新药业有限责任公司 | 国药准字H20060164 | 0.25g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010102753 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20193269 | 0.5g | Category B (乙) | XA10BAE021A010010102770 | NHSA |
| 山西华元医药生物技术有限公司 | 国药准字H20060815 | 0.5g | Category B (乙) | XA10BAE021A010010102865 | NHSA |
| 山西津华晖星制药有限公司 | 国药准字H20050241 | 0.5g | Category B (乙) | XA10BAE021A010010102897 | NHSA |
| 亚宝药业集团股份有限公司 | 国药准字H20080411 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010102987 | NHSA |
| 河南福森药业有限公司 | 国药准字H20080279 | 0.5g | Category B (乙) | XA10BAE021A010010103020 | NHSA |
| 河南羚锐制药股份有限公司 | 国药准字H20243635 | 500mg | Category B (乙) | XA10BAE021A010010103050 | NHSA |
| 天方药业有限公司 | 国药准字H20031225 | 0.5g | Category B (乙) | XA10BAE021A010010103098 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010010103678 | NHSA |
| 哈尔滨珍宝制药有限公司 | 国药准字H20233284 | 0.5g | Category B (乙) | XA10BAE021A010010103783 | NHSA |
| 山东明仁福瑞达制药股份有限公司 | 国药准字H20052118 | 0.5g | Category B (乙) | XA10BAE021A010010103965 | NHSA |
| 青岛黄海制药有限责任公司 | 国药准字H20040154 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010104043 | NHSA |
| 山东凤凰制药股份有限公司 | 国药准字H20051542 | 0.5g | Category B (乙) | XA10BAE021A010010104085 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010104105 | NHSA |
| 山东司邦得制药有限公司 | 国药准字H20060230 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010104125 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20213623 | 0.5g | Category B (乙) | XA10BAE021A010010104127 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20050374 | 0.5g | Category B (乙) | XA10BAE021A010010104145 | NHSA |
| 山东新时代药业有限公司 | 国药准字H20223229 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010104188 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010010104206 | NHSA |
| 浙江易泽达医药科技有限公司 | 国药准字H20223245 | 0.5g | Category B (乙) | XA10BAE021A010010104642 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20060970 | 0.5g | Category B (乙) | XA10BAE021A010010104647 | NHSA |
| 浙江京新药业股份有限公司 | 国药准字H20243541 | 0.5g | Category B (乙) | XA10BAE021A010010104658 | NHSA |
| 浙江苏可安药业有限公司 | 国药准字H20080146 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010104681 | NHSA |
| 浙江三生蔓迪药业有限公司 | 国药准字H20080103 | 0.5g | Category B (乙) | XA10BAE021A010010104726 | NHSA |
| 福州辰星药业有限公司 | 国药准字H20080432 | 0.25g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010104824 | NHSA |
| 海南海力制药有限公司 | 国药准字H20050070 | 0.5g | Category B (乙) | XA10BAE021A010010105774 | NHSA |
| 海南海灵化学制药有限公司 | 国药准字H20203613 | 0.5g | Category B (乙) | XA10BAE021A010010105775 | NHSA |
| 海南普利制药股份有限公司 | 国药准字H20040971 | 0.5g | Category B (乙) | XA10BAE021A010010105801 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20080251 | 0.25g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010106632 | NHSA |
| 河北山姆士药业有限公司 | 国药准字H20123024 | 0.5g | Category B (乙) | XA10BAE021A010010109602 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010179260 | NHSA |
| 重庆锐恩医药有限公司 | 国药准字H20193023 | 0.5g | Category B (乙) | XA10BAE021A010010181522 | NHSA |
| 乐声药业石家庄有限公司 | 国药准字H20233061 | 0.5g | Category B (乙) | XA10BAE021A010010183420 | NHSA |
| 浙江众延医药科技有限公司 | 国药准字H20244548 | 1.0g | Category B (乙) | XA10BAE021A010010184225 | NHSA |
| 山东汇泽生物制药有限公司 | 国药准字H20244835 | 0.5g | Category B (乙) | XA10BAE021A010010184619 | NHSA |
| 北京万辉双鹤药业有限责任公司 | 国药准字H20041986 | 0.5g | Category B (乙) | XA10BAE021A010010200176 | NHSA |
| 悦康药业集团股份有限公司 | 国药准字H20051289 | 0.5g | Category B (乙) | XA10BAE021A010010200239 | NHSA |
| 深圳市中联制药有限公司 | 国药准字H20041221 | 0.5g | Category B (乙) | XA10BAE021A010010200543 | NHSA |
| 恒昌(广州)新药研究有限公司 | 国药准字H20050052 | 0.5g | Category B (乙) | XA10BAE021A010010200732 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010010201021 | NHSA |
| 苏中药业集团股份有限公司 | 国药准字H20051117 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010201493 | NHSA |
| 江苏祥瑞药业有限公司 | 国药准字H20051653 | 0.5g | Category B (乙) | XA10BAE021A010010201506 | NHSA |
| 正大天晴药业集团股份有限公司 | 国药准字H20031104 | 0.5g | Category B (乙) | XA10BAE021A010010201523 | NHSA |
| 山西同达药业有限公司 | 国药准字H20100173 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010201534 | NHSA |
| 南京亿华药业有限公司 | 国药准字H20040816 | 0.5g | Category B (乙) | XA10BAE021A010010201604 | NHSA |
| 苏州东瑞制药有限公司 | 国药准字H20060501 | 0.5g | Category B (乙) | XA10BAE021A010010201650 | NHSA |
| 宜昌人福药业有限责任公司 | 国药准字H20203371 | 500mg(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010202000 | NHSA |
| 成都倍特药业股份有限公司 | 国药准字H20213488 | 0.5g | Category B (乙) | XA10BAE021A010010202013 | NHSA |
| 成都恒瑞制药有限公司 | 国药准字H20030952 | 0.5g | Category B (乙) | XA10BAE021A010010202031 | NHSA |
| 石家庄市华新药业有限责任公司 | 国药准字H20060164 | 0.25g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010202753 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20193269 | 0.5g | Category B (乙) | XA10BAE021A010010202770 | NHSA |
| 山西华元医药生物技术有限公司 | 国药准字H20060815 | 0.5g | Category B (乙) | XA10BAE021A010010202865 | NHSA |
| 山西津华晖星制药有限公司 | 国药准字H20050241 | 0.5g | Category B (乙) | XA10BAE021A010010202897 | NHSA |
| 亚宝药业集团股份有限公司 | 国药准字H20080411 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010202987 | NHSA |
| 河南福森药业有限公司 | 国药准字H20080279 | 0.5g | Category B (乙) | XA10BAE021A010010203020 | NHSA |
| 天方药业有限公司 | 国药准字H20031225 | 0.5g | Category B (乙) | XA10BAE021A010010203098 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010010203678 | NHSA |
| 哈尔滨珍宝制药有限公司 | 国药准字H20233284 | 0.5g | Category B (乙) | XA10BAE021A010010203783 | NHSA |
| 山东明仁福瑞达制药股份有限公司 | 国药准字H20052118 | 0.5g | Category B (乙) | XA10BAE021A010010203965 | NHSA |
| 青岛黄海制药有限责任公司 | 国药准字H20040154 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010204043 | NHSA |
| 山东凤凰制药股份有限公司 | 国药准字H20051542 | 0.5g | Category B (乙) | XA10BAE021A010010204085 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010204105 | NHSA |
| 山东司邦得制药有限公司 | 国药准字H20060230 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010204125 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20213623 | 0.5g | Category B (乙) | XA10BAE021A010010204127 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20050374 | 0.5g | Category B (乙) | XA10BAE021A010010204145 | NHSA |
| 山东新时代药业有限公司 | 国药准字H20223229 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010204188 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010010204206 | NHSA |
| 浙江易泽达医药科技有限公司 | 国药准字H20223245 | 0.5g | Category B (乙) | XA10BAE021A010010204642 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20060970 | 0.5g | Category B (乙) | XA10BAE021A010010204647 | NHSA |
| 海南海力制药有限公司 | 国药准字H20050070 | 0.5g | Category B (乙) | XA10BAE021A010010205774 | NHSA |
| 海南普利制药股份有限公司 | 国药准字H20040971 | 0.5g | Category B (乙) | XA10BAE021A010010205801 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20080251 | 0.25g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010206632 | NHSA |
| 河北山姆士药业有限公司 | 国药准字H20123024 | 0.5g | Category B (乙) | XA10BAE021A010010209602 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010279260 | NHSA |
| 乐声药业石家庄有限公司 | 国药准字H20233061 | 0.5g | Category B (乙) | XA10BAE021A010010283420 | NHSA |
| 浙江众延医药科技有限公司 | 国药准字H20244548 | 1.0g | Category B (乙) | XA10BAE021A010010284225 | NHSA |
| 山东汇泽生物制药有限公司 | 国药准字H20244835 | 0.5g | Category B (乙) | XA10BAE021A010010284619 | NHSA |
| 北京万辉双鹤药业有限责任公司 | 国药准字H20041986 | 0.5g | Category B (乙) | XA10BAE021A010010300176 | NHSA |
| 悦康药业集团股份有限公司 | 国药准字H20051289 | 0.5g | Category B (乙) | XA10BAE021A010010300239 | NHSA |
| 深圳市中联制药有限公司 | 国药准字H20041221 | 0.5g | Category B (乙) | XA10BAE021A010010300543 | NHSA |
| 恒昌(广州)新药研究有限公司 | 国药准字H20050052 | 0.5g | Category B (乙) | XA10BAE021A010010300732 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010010301021 | NHSA |
| 苏中药业集团股份有限公司 | 国药准字H20051117 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010301493 | NHSA |
| 江苏祥瑞药业有限公司 | 国药准字H20051653 | 0.5g | Category B (乙) | XA10BAE021A010010301506 | NHSA |
| 正大天晴药业集团股份有限公司 | 国药准字H20031104 | 0.5g | Category B (乙) | XA10BAE021A010010301523 | NHSA |
| 南京亿华药业有限公司 | 国药准字H20040816 | 0.5g | Category B (乙) | XA10BAE021A010010301604 | NHSA |
| 苏州东瑞制药有限公司 | 国药准字H20060501 | 0.5g | Category B (乙) | XA10BAE021A010010301650 | NHSA |
| 成都恒瑞制药有限公司 | 国药准字H20030952 | 0.5g | Category B (乙) | XA10BAE021A010010302031 | NHSA |
| 石家庄市华新药业有限责任公司 | 国药准字H20060164 | 0.25g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010302753 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20193269 | 0.5g | Category B (乙) | XA10BAE021A010010302770 | NHSA |
| 山西华元医药生物技术有限公司 | 国药准字H20060815 | 0.5g | Category B (乙) | XA10BAE021A010010302865 | NHSA |
| 山西津华晖星制药有限公司 | 国药准字H20050241 | 0.5g | Category B (乙) | XA10BAE021A010010302897 | NHSA |
| 河南福森药业有限公司 | 国药准字H20080279 | 0.5g | Category B (乙) | XA10BAE021A010010303020 | NHSA |
| 天方药业有限公司 | 国药准字H20031225 | 0.5g | Category B (乙) | XA10BAE021A010010303098 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010010303678 | NHSA |
| 青岛黄海制药有限责任公司 | 国药准字H20040154 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010304043 | NHSA |
| 山东凤凰制药股份有限公司 | 国药准字H20051542 | 0.5g | Category B (乙) | XA10BAE021A010010304085 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010304105 | NHSA |
| 山东司邦得制药有限公司 | 国药准字H20060230 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010304125 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20213623 | 0.5g | Category B (乙) | XA10BAE021A010010304127 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20050374 | 0.5g | Category B (乙) | XA10BAE021A010010304145 | NHSA |
| 山东新时代药业有限公司 | 国药准字H20223229 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010304188 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010010304206 | NHSA |
| 浙江易泽达医药科技有限公司 | 国药准字H20223245 | 0.5g | Category B (乙) | XA10BAE021A010010304642 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20060970 | 0.5g | Category B (乙) | XA10BAE021A010010304647 | NHSA |
| 海南海力制药有限公司 | 国药准字H20050070 | 0.5g | Category B (乙) | XA10BAE021A010010305774 | NHSA |
| 海南普利制药股份有限公司 | 国药准字H20040971 | 0.5g | Category B (乙) | XA10BAE021A010010305801 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20080251 | 0.25g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010306632 | NHSA |
| 河北山姆士药业有限公司 | 国药准字H20123024 | 0.5g | Category B (乙) | XA10BAE021A010010309602 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010379260 | NHSA |
| 乐声药业石家庄有限公司 | 国药准字H20233061 | 0.5g | Category B (乙) | XA10BAE021A010010383420 | NHSA |
| 浙江众延医药科技有限公司 | 国药准字H20244548 | 1.0g | Category B (乙) | XA10BAE021A010010384225 | NHSA |
| 山东汇泽生物制药有限公司 | 国药准字H20244835 | 0.5g | Category B (乙) | XA10BAE021A010010384619 | NHSA |
| 悦康药业集团股份有限公司 | 国药准字H20051289 | 0.5g | Category B (乙) | XA10BAE021A010010400239 | NHSA |
| 深圳市中联制药有限公司 | 国药准字H20041221 | 0.5g | Category B (乙) | XA10BAE021A010010400543 | NHSA |
| 恒昌(广州)新药研究有限公司 | 国药准字H20050052 | 0.5g | Category B (乙) | XA10BAE021A010010400732 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010010401021 | NHSA |
| 江苏祥瑞药业有限公司 | 国药准字H20051653 | 0.5g | Category B (乙) | XA10BAE021A010010401506 | NHSA |
| 正大天晴药业集团股份有限公司 | 国药准字H20031104 | 0.5g | Category B (乙) | XA10BAE021A010010401523 | NHSA |
| 南京亿华药业有限公司 | 国药准字H20040816 | 0.5g | Category B (乙) | XA10BAE021A010010401604 | NHSA |
| 苏州东瑞制药有限公司 | 国药准字H20060501 | 0.5g | Category B (乙) | XA10BAE021A010010401650 | NHSA |
| 成都恒瑞制药有限公司 | 国药准字H20030952 | 0.5g | Category B (乙) | XA10BAE021A010010402031 | NHSA |
| 石家庄市华新药业有限责任公司 | 国药准字H20060164 | 0.25g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010402753 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20193269 | 0.5g | Category B (乙) | XA10BAE021A010010402770 | NHSA |
| 山西华元医药生物技术有限公司 | 国药准字H20060815 | 0.5g | Category B (乙) | XA10BAE021A010010402865 | NHSA |
| 山西津华晖星制药有限公司 | 国药准字H20050241 | 0.5g | Category B (乙) | XA10BAE021A010010402897 | NHSA |
| 河南福森药业有限公司 | 国药准字H20080279 | 0.5g | Category B (乙) | XA10BAE021A010010403020 | NHSA |
| 天方药业有限公司 | 国药准字H20031225 | 0.5g | Category B (乙) | XA10BAE021A010010403098 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010010403678 | NHSA |
| 山东明仁福瑞达制药股份有限公司 | 国药准字H20052118 | 0.5g | Category B (乙) | XA10BAE021A010010403965 | NHSA |
| 青岛黄海制药有限责任公司 | 国药准字H20040154 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010404043 | NHSA |
| 山东凤凰制药股份有限公司 | 国药准字H20051542 | 0.5g | Category B (乙) | XA10BAE021A010010404085 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010404105 | NHSA |
| 山东司邦得制药有限公司 | 国药准字H20060230 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010404125 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20213623 | 0.5g | Category B (乙) | XA10BAE021A010010404127 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20050374 | 0.5g | Category B (乙) | XA10BAE021A010010404145 | NHSA |
| 山东新时代药业有限公司 | 国药准字H20223229 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010404188 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010010404206 | NHSA |
| 浙江易泽达医药科技有限公司 | 国药准字H20223245 | 0.5g | Category B (乙) | XA10BAE021A010010404642 | NHSA |
| 南昌市飞弘药业有限公司 | 国药准字H20051662 | 0.5g | Category B (乙) | XA10BAE021A010010405406 | NHSA |
| 海南海力制药有限公司 | 国药准字H20050070 | 0.5g | Category B (乙) | XA10BAE021A010010405774 | NHSA |
| 海南普利制药股份有限公司 | 国药准字H20040971 | 0.5g | Category B (乙) | XA10BAE021A010010405801 | NHSA |
| 河北山姆士药业有限公司 | 国药准字H20123024 | 0.5g | Category B (乙) | XA10BAE021A010010409602 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010479260 | NHSA |
| 浙江众延医药科技有限公司 | 国药准字H20244548 | 1.0g | Category B (乙) | XA10BAE021A010010484225 | NHSA |
| 山东汇泽生物制药有限公司 | 国药准字H20244835 | 0.5g | Category B (乙) | XA10BAE021A010010484619 | NHSA |
| 恒昌(广州)新药研究有限公司 | 国药准字H20050052 | 0.5g | Category B (乙) | XA10BAE021A010010500732 | NHSA |
| 江苏祥瑞药业有限公司 | 国药准字H20051653 | 0.5g | Category B (乙) | XA10BAE021A010010501506 | NHSA |
| 正大天晴药业集团股份有限公司 | 国药准字H20031104 | 0.5g | Category B (乙) | XA10BAE021A010010501523 | NHSA |
| 南京亿华药业有限公司 | 国药准字H20040816 | 0.5g | Category B (乙) | XA10BAE021A010010501604 | NHSA |
| 苏州东瑞制药有限公司 | 国药准字H20060501 | 0.5g | Category B (乙) | XA10BAE021A010010501650 | NHSA |
| 成都恒瑞制药有限公司 | 国药准字H20030952 | 0.5g | Category B (乙) | XA10BAE021A010010502031 | NHSA |
| 山西华元医药生物技术有限公司 | 国药准字H20060815 | 0.5g | Category B (乙) | XA10BAE021A010010502865 | NHSA |
| 山西津华晖星制药有限公司 | 国药准字H20050241 | 0.5g | Category B (乙) | XA10BAE021A010010502897 | NHSA |
| 河南福森药业有限公司 | 国药准字H20080279 | 0.5g | Category B (乙) | XA10BAE021A010010503020 | NHSA |
| 天方药业有限公司 | 国药准字H20031225 | 0.5g | Category B (乙) | XA10BAE021A010010503098 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010010503678 | NHSA |
| 山东凤凰制药股份有限公司 | 国药准字H20051542 | 0.5g | Category B (乙) | XA10BAE021A010010504085 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010504105 | NHSA |
| 山东司邦得制药有限公司 | 国药准字H20060230 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010504125 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20213623 | 0.5g | Category B (乙) | XA10BAE021A010010504127 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20050374 | 0.5g | Category B (乙) | XA10BAE021A010010504145 | NHSA |
| 山东新时代药业有限公司 | 国药准字H20223229 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010504188 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010010504206 | NHSA |
| 浙江易泽达医药科技有限公司 | 国药准字H20223245 | 0.5g | Category B (乙) | XA10BAE021A010010504642 | NHSA |
| 南昌市飞弘药业有限公司 | 国药准字H20051662 | 0.5g | Category B (乙) | XA10BAE021A010010505406 | NHSA |
| 海南海力制药有限公司 | 国药准字H20050070 | 0.5g | Category B (乙) | XA10BAE021A010010505774 | NHSA |
| 海南普利制药股份有限公司 | 国药准字H20040971 | 0.5g | Category B (乙) | XA10BAE021A010010505801 | NHSA |
| 河北山姆士药业有限公司 | 国药准字H20123024 | 0.5g | Category B (乙) | XA10BAE021A010010509602 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010579260 | NHSA |
| 浙江众延医药科技有限公司 | 国药准字H20244548 | 1.0g | Category B (乙) | XA10BAE021A010010584225 | NHSA |
| 山东汇泽生物制药有限公司 | 国药准字H20244835 | 0.5g | Category B (乙) | XA10BAE021A010010584619 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010010601021 | NHSA |
| 江苏祥瑞药业有限公司 | 国药准字H20051653 | 0.5g | Category B (乙) | XA10BAE021A010010601506 | NHSA |
| 正大天晴药业集团股份有限公司 | 国药准字H20031104 | 0.5g | Category B (乙) | XA10BAE021A010010601523 | NHSA |
| 成都恒瑞制药有限公司 | 国药准字H20030952 | 0.5g | Category B (乙) | XA10BAE021A010010602031 | NHSA |
| 山西华元医药生物技术有限公司 | 国药准字H20060815 | 0.5g | Category B (乙) | XA10BAE021A010010602865 | NHSA |
| 河南福森药业有限公司 | 国药准字H20080279 | 0.5g | Category B (乙) | XA10BAE021A010010603020 | NHSA |
| 天方药业有限公司 | 国药准字H20031225 | 0.5g | Category B (乙) | XA10BAE021A010010603098 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010010603678 | NHSA |
| 山东凤凰制药股份有限公司 | 国药准字H20051542 | 0.5g | Category B (乙) | XA10BAE021A010010604085 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010604105 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20213623 | 0.5g | Category B (乙) | XA10BAE021A010010604127 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20050374 | 0.5g | Category B (乙) | XA10BAE021A010010604145 | NHSA |
| 山东新时代药业有限公司 | 国药准字H20223229 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010604188 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010010604206 | NHSA |
| 浙江易泽达医药科技有限公司 | 国药准字H20223245 | 0.5g | Category B (乙) | XA10BAE021A010010604642 | NHSA |
| 海南普利制药股份有限公司 | 国药准字H20040971 | 0.5g | Category B (乙) | XA10BAE021A010010605801 | NHSA |
| 河北山姆士药业有限公司 | 国药准字H20123024 | 0.5g | Category B (乙) | XA10BAE021A010010609602 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010679260 | NHSA |
| 浙江众延医药科技有限公司 | 国药准字H20244548 | 1.0g | Category B (乙) | XA10BAE021A010010684225 | NHSA |
| 恒昌(广州)新药研究有限公司 | 国药准字H20050052 | 0.5g | Category B (乙) | XA10BAE021A010010700732 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010010701021 | NHSA |
| 江苏祥瑞药业有限公司 | 国药准字H20051653 | 0.5g | Category B (乙) | XA10BAE021A010010701506 | NHSA |
| 山西华元医药生物技术有限公司 | 国药准字H20060815 | 0.5g | Category B (乙) | XA10BAE021A010010702865 | NHSA |
| 山西津华晖星制药有限公司 | 国药准字H20050241 | 0.5g | Category B (乙) | XA10BAE021A010010702897 | NHSA |
| 河南福森药业有限公司 | 国药准字H20080279 | 0.5g | Category B (乙) | XA10BAE021A010010703020 | NHSA |
| 天方药业有限公司 | 国药准字H20031225 | 0.5g | Category B (乙) | XA10BAE021A010010703098 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010010703678 | NHSA |
| 山东凤凰制药股份有限公司 | 国药准字H20051542 | 0.5g | Category B (乙) | XA10BAE021A010010704085 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010704105 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20213623 | 0.5g | Category B (乙) | XA10BAE021A010010704127 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20050374 | 0.5g | Category B (乙) | XA10BAE021A010010704145 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010010704206 | NHSA |
| 浙江易泽达医药科技有限公司 | 国药准字H20223245 | 0.5g | Category B (乙) | XA10BAE021A010010704642 | NHSA |
| 海南普利制药股份有限公司 | 国药准字H20040971 | 0.5g | Category B (乙) | XA10BAE021A010010705801 | NHSA |
| 河北山姆士药业有限公司 | 国药准字H20123024 | 0.5g | Category B (乙) | XA10BAE021A010010709602 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010779260 | NHSA |
| 浙江众延医药科技有限公司 | 国药准字H20244548 | 1.0g | Category B (乙) | XA10BAE021A010010784225 | NHSA |
| 恒昌(广州)新药研究有限公司 | 国药准字H20050052 | 0.5g | Category B (乙) | XA10BAE021A010010800732 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010010801021 | NHSA |
| 江苏祥瑞药业有限公司 | 国药准字H20051653 | 0.5g | Category B (乙) | XA10BAE021A010010801506 | NHSA |
| 山西华元医药生物技术有限公司 | 国药准字H20060815 | 0.5g | Category B (乙) | XA10BAE021A010010802865 | NHSA |
| 山西津华晖星制药有限公司 | 国药准字H20050241 | 0.5g | Category B (乙) | XA10BAE021A010010802897 | NHSA |
| 天方药业有限公司 | 国药准字H20031225 | 0.5g | Category B (乙) | XA10BAE021A010010803098 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010010803678 | NHSA |
| 山东凤凰制药股份有限公司 | 国药准字H20051542 | 0.5g | Category B (乙) | XA10BAE021A010010804085 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010804105 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20213623 | 0.5g | Category B (乙) | XA10BAE021A010010804127 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010010804206 | NHSA |
| 浙江易泽达医药科技有限公司 | 国药准字H20223245 | 0.5g | Category B (乙) | XA10BAE021A010010804642 | NHSA |
| 海南普利制药股份有限公司 | 国药准字H20040971 | 0.5g | Category B (乙) | XA10BAE021A010010805801 | NHSA |
| 河北山姆士药业有限公司 | 国药准字H20123024 | 0.5g | Category B (乙) | XA10BAE021A010010809602 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010879260 | NHSA |
| 浙江众延医药科技有限公司 | 国药准字H20244548 | 1.0g | Category B (乙) | XA10BAE021A010010884225 | NHSA |
| 恒昌(广州)新药研究有限公司 | 国药准字H20050052 | 0.5g | Category B (乙) | XA10BAE021A010010900732 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010010901021 | NHSA |
| 江苏祥瑞药业有限公司 | 国药准字H20051653 | 0.5g | Category B (乙) | XA10BAE021A010010901506 | NHSA |
| 山西华元医药生物技术有限公司 | 国药准字H20060815 | 0.5g | Category B (乙) | XA10BAE021A010010902865 | NHSA |
| 山西津华晖星制药有限公司 | 国药准字H20050241 | 0.5g | Category B (乙) | XA10BAE021A010010902897 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010010903678 | NHSA |
| 山东凤凰制药股份有限公司 | 国药准字H20051542 | 0.5g | Category B (乙) | XA10BAE021A010010904085 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010904105 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20213623 | 0.5g | Category B (乙) | XA10BAE021A010010904127 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010010904206 | NHSA |
| 浙江易泽达医药科技有限公司 | 国药准字H20223245 | 0.5g | Category B (乙) | XA10BAE021A010010904642 | NHSA |
| 海南普利制药股份有限公司 | 国药准字H20040971 | 0.5g | Category B (乙) | XA10BAE021A010010905801 | NHSA |
| 河北山姆士药业有限公司 | 国药准字H20123024 | 0.5g | Category B (乙) | XA10BAE021A010010909602 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010010979260 | NHSA |
| 浙江众延医药科技有限公司 | 国药准字H20244548 | 1.0g | Category B (乙) | XA10BAE021A010010984225 | NHSA |
| 恒昌(广州)新药研究有限公司 | 国药准字H20050052 | 0.5g | Category B (乙) | XA10BAE021A010011000732 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010011001021 | NHSA |
| 江苏祥瑞药业有限公司 | 国药准字H20051653 | 0.5g | Category B (乙) | XA10BAE021A010011001506 | NHSA |
| 山西华元医药生物技术有限公司 | 国药准字H20060815 | 0.5g | Category B (乙) | XA10BAE021A010011002865 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010011003678 | NHSA |
| 山东凤凰制药股份有限公司 | 国药准字H20051542 | 0.5g | Category B (乙) | XA10BAE021A010011004085 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010011004105 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20213623 | 0.5g | Category B (乙) | XA10BAE021A010011004127 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010011004206 | NHSA |
| 浙江易泽达医药科技有限公司 | 国药准字H20223245 | 0.5g | Category B (乙) | XA10BAE021A010011004642 | NHSA |
| 海南普利制药股份有限公司 | 国药准字H20040971 | 0.5g | Category B (乙) | XA10BAE021A010011005801 | NHSA |
| 河北山姆士药业有限公司 | 国药准字H20123024 | 0.5g | Category B (乙) | XA10BAE021A010011009602 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010011079260 | NHSA |
| 浙江众延医药科技有限公司 | 国药准字H20244548 | 1.0g | Category B (乙) | XA10BAE021A010011084225 | NHSA |
| 恒昌(广州)新药研究有限公司 | 国药准字H20050052 | 0.5g | Category B (乙) | XA10BAE021A010011100732 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010011101021 | NHSA |
| 山西华元医药生物技术有限公司 | 国药准字H20060815 | 0.5g | Category B (乙) | XA10BAE021A010011102865 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010011103678 | NHSA |
| 山东凤凰制药股份有限公司 | 国药准字H20051542 | 0.5g | Category B (乙) | XA10BAE021A010011104085 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010011104105 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20213623 | 0.5g | Category B (乙) | XA10BAE021A010011104127 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010011104206 | NHSA |
| 浙江易泽达医药科技有限公司 | 国药准字H20223245 | 0.5g | Category B (乙) | XA10BAE021A010011104642 | NHSA |
| 海南普利制药股份有限公司 | 国药准字H20040971 | 0.5g | Category B (乙) | XA10BAE021A010011105801 | NHSA |
| 河北山姆士药业有限公司 | 国药准字H20123024 | 0.5g | Category B (乙) | XA10BAE021A010011109602 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010011179260 | NHSA |
| 浙江众延医药科技有限公司 | 国药准字H20244548 | 1.0g | Category B (乙) | XA10BAE021A010011184225 | NHSA |
| 恒昌(广州)新药研究有限公司 | 国药准字H20050052 | 0.5g | Category B (乙) | XA10BAE021A010011200732 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010011201021 | NHSA |
| 山西华元医药生物技术有限公司 | 国药准字H20060815 | 0.5g | Category B (乙) | XA10BAE021A010011202865 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010011203678 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010011204105 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20213623 | 0.5g | Category B (乙) | XA10BAE021A010011204127 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010011204206 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010011279260 | NHSA |
| 浙江众延医药科技有限公司 | 国药准字H20244548 | 1.0g | Category B (乙) | XA10BAE021A010011284225 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010011301021 | NHSA |
| 山西华元医药生物技术有限公司 | 国药准字H20060815 | 0.5g | Category B (乙) | XA10BAE021A010011302865 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010011303678 | NHSA |
| 山东凤凰制药股份有限公司 | 国药准字H20051542 | 0.5g | Category B (乙) | XA10BAE021A010011304085 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20213623 | 0.5g | Category B (乙) | XA10BAE021A010011304127 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010011304206 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010011379260 | NHSA |
| 浙江众延医药科技有限公司 | 国药准字H20244548 | 1.0g | Category B (乙) | XA10BAE021A010011384225 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010011401021 | NHSA |
| 山西华元医药生物技术有限公司 | 国药准字H20060815 | 0.5g | Category B (乙) | XA10BAE021A010011402865 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010011403678 | NHSA |
| 山东凤凰制药股份有限公司 | 国药准字H20051542 | 0.5g | Category B (乙) | XA10BAE021A010011404085 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20213623 | 0.5g | Category B (乙) | XA10BAE021A010011404127 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010011404206 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010011479260 | NHSA |
| 浙江众延医药科技有限公司 | 国药准字H20244548 | 1.0g | Category B (乙) | XA10BAE021A010011484225 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010011501021 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010011503678 | NHSA |
| 山东凤凰制药股份有限公司 | 国药准字H20051542 | 0.5g | Category B (乙) | XA10BAE021A010011504085 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20213623 | 0.5g | Category B (乙) | XA10BAE021A010011504127 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010011504206 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010011579260 | NHSA |
| 浙江众延医药科技有限公司 | 国药准字H20244548 | 1.0g | Category B (乙) | XA10BAE021A010011584225 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010011601021 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010011603678 | NHSA |
| 山东凤凰制药股份有限公司 | 国药准字H20051542 | 0.5g | Category B (乙) | XA10BAE021A010011604085 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20213623 | 0.5g | Category B (乙) | XA10BAE021A010011604127 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010011604206 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010011679260 | NHSA |
| 浙江众延医药科技有限公司 | 国药准字H20244548 | 1.0g | Category B (乙) | XA10BAE021A010011684225 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010011701021 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010011703678 | NHSA |
| 山东凤凰制药股份有限公司 | 国药准字H20051542 | 0.5g | Category B (乙) | XA10BAE021A010011704085 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20213623 | 0.5g | Category B (乙) | XA10BAE021A010011704127 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010011704206 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010011779260 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010011801021 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010011803678 | NHSA |
| 山东凤凰制药股份有限公司 | 国药准字H20051542 | 0.5g | Category B (乙) | XA10BAE021A010011804085 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20213623 | 0.5g | Category B (乙) | XA10BAE021A010011804127 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010011804206 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010011879260 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010011901021 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010011903678 | NHSA |
| 山东凤凰制药股份有限公司 | 国药准字H20051542 | 0.5g | Category B (乙) | XA10BAE021A010011904085 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20213623 | 0.5g | Category B (乙) | XA10BAE021A010011904127 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010011904206 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010011979260 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010012001021 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010012003678 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20213623 | 0.5g | Category B (乙) | XA10BAE021A010012004127 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010012004206 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010012079260 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010012101021 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010012103678 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010012104206 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010012201021 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010012203678 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010012204206 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010012279260 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010012301021 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010012303678 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010012304206 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010012379260 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010012401021 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010012403678 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010012404206 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010012501021 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010012503678 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010012504206 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010012601021 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010012603678 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010012604206 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010012701021 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010012704206 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010012801021 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010012901021 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010013001021 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010013101021 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010013201021 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010013301021 | NHSA |
| 重庆科瑞南海制药有限责任公司 | 国药准字H20050349 | 0.5g | Category B (乙) | XA10BAE021A010013401021 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20090120 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010020100248 | NHSA |
| 辽宁奥达制药有限公司 | 国药准字H20070117 | 0.5g | Category B (乙) | XA10BAE021A010020101351 | NHSA |
| 江苏祥瑞药业有限公司 | 国药准字H20051653 | 0.5g | Category B (乙) | XA10BAE021A010020101506 | NHSA |
| 山西同达药业有限公司 | 国药准字H20100173 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010020101534 | NHSA |
| 宜昌人福药业有限责任公司 | 国药准字H20203312 | 750mg(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010020102000 | NHSA |
| 石家庄市华新药业有限责任公司 | 国药准字H20140023 | 0.5g | Category B (乙) | XA10BAE021A010020102753 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20193270 | 0.75g | Category B (乙) | XA10BAE021A010020102770 | NHSA |
| 山西华元医药生物技术有限公司 | 国药准字H20060815 | 0.5g | Category B (乙) | XA10BAE021A010020102865 | NHSA |
| 山西津华晖星制药有限公司 | 国药准字H20050241 | 0.5g | Category B (乙) | XA10BAE021A010020102897 | NHSA |
| 天方药业有限公司 | 国药准字H20031225 | 0.5g | Category B (乙) | XA10BAE021A010020103098 | NHSA |
| 青岛黄海生物制药有限责任公司 | 国药准字H20234038 | 0.5g | Category B (乙) | XA10BAE021A010020104043 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010020104105 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20213623 | 0.5g | Category B (乙) | XA10BAE021A010020104127 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20050374 | 0.5g | Category B (乙) | XA10BAE021A010020104145 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010020104206 | NHSA |
| 南昌市飞弘药业有限公司 | 国药准字H20051662 | 0.5g | Category B (乙) | XA10BAE021A010020105406 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20080252 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010020106632 | NHSA |
| 河北山姆士药业有限公司 | 国药准字H20123024 | 0.5g | Category B (乙) | XA10BAE021A010020109602 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010020179260 | NHSA |
| 默克制药(江苏)有限公司 | 国药准字H20227043 | 0.5g | Category B (乙) | XA10BAE021A010020181152 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20090120 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010020200248 | NHSA |
| 江苏祥瑞药业有限公司 | 国药准字H20051653 | 0.5g | Category B (乙) | XA10BAE021A010020201506 | NHSA |
| 山西同达药业有限公司 | 国药准字H20100173 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010020201534 | NHSA |
| 宜昌人福药业有限责任公司 | 国药准字H20203312 | 750mg(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010020202000 | NHSA |
| 石家庄市华新药业有限责任公司 | 国药准字H20140023 | 0.5g | Category B (乙) | XA10BAE021A010020202753 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20193270 | 0.75g | Category B (乙) | XA10BAE021A010020202770 | NHSA |
| 山西华元医药生物技术有限公司 | 国药准字H20060815 | 0.5g | Category B (乙) | XA10BAE021A010020202865 | NHSA |
| 青岛黄海生物制药有限责任公司 | 国药准字H20234038 | 0.5g | Category B (乙) | XA10BAE021A010020204043 | NHSA |
| 南昌市飞弘药业有限公司 | 国药准字H20051662 | 0.5g | Category B (乙) | XA10BAE021A010020205406 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20080252 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010020206632 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20090120 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010020300248 | NHSA |
| 山西同达药业有限公司 | 国药准字H20100173 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010020301534 | NHSA |
| 石家庄市华新药业有限责任公司 | 国药准字H20140023 | 0.5g | Category B (乙) | XA10BAE021A010020302753 | NHSA |
| 山西华元医药生物技术有限公司 | 国药准字H20060815 | 0.5g | Category B (乙) | XA10BAE021A010020302865 | NHSA |
| 青岛黄海生物制药有限责任公司 | 国药准字H20234038 | 0.5g | Category B (乙) | XA10BAE021A010020304043 | NHSA |
| 南昌市飞弘药业有限公司 | 国药准字H20051662 | 0.5g | Category B (乙) | XA10BAE021A010020305406 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20080252 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010020306632 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20090120 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010020400248 | NHSA |
| 山西同达药业有限公司 | 国药准字H20100173 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010020401534 | NHSA |
| 石家庄市华新药业有限责任公司 | 国药准字H20140023 | 0.5g | Category B (乙) | XA10BAE021A010020402753 | NHSA |
| 山西华元医药生物技术有限公司 | 国药准字H20060815 | 0.5g | Category B (乙) | XA10BAE021A010020402865 | NHSA |
| 青岛黄海生物制药有限责任公司 | 国药准字H20234038 | 0.5g | Category B (乙) | XA10BAE021A010020404043 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20090120 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010020500248 | NHSA |
| 山西同达药业有限公司 | 国药准字H20100173 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010020501534 | NHSA |
| 石家庄市华新药业有限责任公司 | 国药准字H20140023 | 0.5g | Category B (乙) | XA10BAE021A010020502753 | NHSA |
| 青岛黄海生物制药有限责任公司 | 国药准字H20234038 | 0.5g | Category B (乙) | XA10BAE021A010020504043 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20090120 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010020600248 | NHSA |
| 石家庄市华新药业有限责任公司 | 国药准字H20140023 | 0.5g | Category B (乙) | XA10BAE021A010020602753 | NHSA |
| 青岛黄海生物制药有限责任公司 | 国药准字H20234038 | 0.5g | Category B (乙) | XA10BAE021A010020604043 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20090120 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010020700248 | NHSA |
| 石家庄市华新药业有限责任公司 | 国药准字H20140023 | 0.5g | Category B (乙) | XA10BAE021A010020702753 | NHSA |
| 青岛黄海生物制药有限责任公司 | 国药准字H20234038 | 0.5g | Category B (乙) | XA10BAE021A010020704043 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20090120 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010020800248 | NHSA |
| 石家庄市华新药业有限责任公司 | 国药准字H20140023 | 0.5g | Category B (乙) | XA10BAE021A010020802753 | NHSA |
| 青岛黄海生物制药有限责任公司 | 国药准字H20234038 | 0.5g | Category B (乙) | XA10BAE021A010020804043 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20050374 | 0.5g | Category B (乙) | XA10BAE021A010020804145 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20090120 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010020900248 | NHSA |
| 石家庄市华新药业有限责任公司 | 国药准字H20140023 | 0.5g | Category B (乙) | XA10BAE021A010020902753 | NHSA |
| 天方药业有限公司 | 国药准字H20031225 | 0.5g | Category B (乙) | XA10BAE021A010020903098 | NHSA |
| 青岛黄海生物制药有限责任公司 | 国药准字H20234038 | 0.5g | Category B (乙) | XA10BAE021A010020904043 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20050374 | 0.5g | Category B (乙) | XA10BAE021A010020904145 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20090120 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010021000248 | NHSA |
| 石家庄市华新药业有限责任公司 | 国药准字H20140023 | 0.5g | Category B (乙) | XA10BAE021A010021002753 | NHSA |
| 天方药业有限公司 | 国药准字H20031225 | 0.5g | Category B (乙) | XA10BAE021A010021003098 | NHSA |
| 青岛黄海生物制药有限责任公司 | 国药准字H20234038 | 0.5g | Category B (乙) | XA10BAE021A010021004043 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20050374 | 0.5g | Category B (乙) | XA10BAE021A010021004145 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20090120 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010021100248 | NHSA |
| 石家庄市华新药业有限责任公司 | 国药准字H20140023 | 0.5g | Category B (乙) | XA10BAE021A010021102753 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20090120 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010021200248 | NHSA |
| 石家庄市华新药业有限责任公司 | 国药准字H20140023 | 0.5g | Category B (乙) | XA10BAE021A010021202753 | NHSA |
| 河北山姆士药业有限公司 | 国药准字H20123024 | 0.5g | Category B (乙) | XA10BAE021A010021209602 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20090120 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010021300248 | NHSA |
| 河北山姆士药业有限公司 | 国药准字H20123024 | 0.5g | Category B (乙) | XA10BAE021A010021309602 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20090120 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010021400248 | NHSA |
| 河北山姆士药业有限公司 | 国药准字H20123024 | 0.5g | Category B (乙) | XA10BAE021A010021409602 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20090120 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010021500248 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20090120 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010021600248 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20090120 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010021700248 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20090120 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010021800248 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20090120 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010021900248 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20213623 | 0.5g | Category B (乙) | XA10BAE021A010022104127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20213623 | 0.5g | Category B (乙) | XA10BAE021A010022204127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20213623 | 0.5g | Category B (乙) | XA10BAE021A010022304127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20213623 | 0.5g | Category B (乙) | XA10BAE021A010022404127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20213623 | 0.5g | Category B (乙) | XA10BAE021A010022504127 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20090120 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010030100248 | NHSA |
| 江苏祥瑞药业有限公司 | 国药准字H20051653 | 0.5g | Category B (乙) | XA10BAE021A010030101506 | NHSA |
| 石家庄市华新药业有限责任公司 | 国药准字H20060164 | 0.25g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010030102753 | NHSA |
| 山西华元医药生物技术有限公司 | 国药准字H20060815 | 0.5g | Category B (乙) | XA10BAE021A010030102865 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010030103678 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010030104105 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010030104206 | NHSA |
| 南昌市飞弘药业有限公司 | 国药准字H20051662 | 0.5g | Category B (乙) | XA10BAE021A010030105406 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20237050 | 0.75g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010030106632 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010030179260 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010030203678 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20237050 | 0.75g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010030206632 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010030303678 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20237050 | 0.75g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010030306632 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20237050 | 0.75g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010030406632 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20237050 | 0.75g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010030506632 | NHSA |
| 江苏祥瑞药业有限公司 | 国药准字H20051653 | 0.5g | Category B (乙) | XA10BAE021A010031101506 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20178002 | 0.5g | Category B (乙) | XA10BAE021A010031180463 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20178002 | 0.5g | Category B (乙) | XA10BAE021A010031280463 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20178002 | 0.5g | Category B (乙) | XA10BAE021A010031380463 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20178002 | 0.5g | Category B (乙) | XA10BAE021A010031480463 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20178002 | 0.5g | Category B (乙) | XA10BAE021A010031580463 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20178002 | 0.5g | Category B (乙) | XA10BAE021A010031680463 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20178002 | 0.5g | Category B (乙) | XA10BAE021A010031780463 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20178002 | 0.5g | Category B (乙) | XA10BAE021A010031880463 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20178002 | 0.5g | Category B (乙) | XA10BAE021A010031980463 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20178002 | 0.5g | Category B (乙) | XA10BAE021A010032080463 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20178002 | 0.5g | Category B (乙) | XA10BAE021A010032180463 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20178002 | 0.5g | Category B (乙) | XA10BAE021A010032280463 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20178002 | 0.5g | Category B (乙) | XA10BAE021A010032380463 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20178002 | 0.5g | Category B (乙) | XA10BAE021A010032480463 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20178002 | 0.5g | Category B (乙) | XA10BAE021A010032580463 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20178002 | 0.5g | Category B (乙) | XA10BAE021A010032680463 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010032703678 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20178002 | 0.5g | Category B (乙) | XA10BAE021A010032780463 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010032803678 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20178002 | 0.5g | Category B (乙) | XA10BAE021A010032880463 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010032903678 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20178002 | 0.5g | Category B (乙) | XA10BAE021A010032980463 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010033003678 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20178002 | 0.5g | Category B (乙) | XA10BAE021A010033080463 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20178002 | 0.5g | Category B (乙) | XA10BAE021A010033180463 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20090120 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010040100248 | NHSA |
| 江苏祥瑞药业有限公司 | 国药准字H20051653 | 0.5g | Category B (乙) | XA10BAE021A010040101506 | NHSA |
| 山西津华晖星制药有限公司 | 国药准字H20050241 | 0.5g | Category B (乙) | XA10BAE021A010040102897 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010040103678 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010040104105 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010040104206 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010040179260 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H20090120 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010050100248 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010050103678 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010050104105 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010050104206 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010050179260 | NHSA |
| 山西津华晖星制药有限公司 | 国药准字H20050241 | 0.5g | Category B (乙) | XA10BAE021A010050202897 | NHSA |
| 山西津华晖星制药有限公司 | 国药准字H20050241 | 0.5g | Category B (乙) | XA10BAE021A010050402897 | NHSA |
| 山西津华晖星制药有限公司 | 国药准字H20050241 | 0.5g | Category B (乙) | XA10BAE021A010050502897 | NHSA |
| 山西津华晖星制药有限公司 | 国药准字H20050241 | 0.5g | Category B (乙) | XA10BAE021A010060102897 | NHSA |
| 哈尔滨同一堂药业有限公司 | 国药准字H20060226 | 0.5g(以C₄H₁₁N₅·HCl计) | Category B (乙) | XA10BAE021A010060103678 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010060104105 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010060104206 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010060179260 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010060204105 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010060304105 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010060404105 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010060504105 | NHSA |
| 山西津华晖星制药有限公司 | 国药准字H20050241 | 0.5g | Category B (乙) | XA10BAE021A010070102897 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010070104105 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010070104206 | NHSA |
| 吉林省益浦生物科技有限公司 | 国药准字H20203361 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010070179260 | NHSA |
| 山西津华晖星制药有限公司 | 国药准字H20050241 | 0.5g | Category B (乙) | XA10BAE021A010080102897 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010080104105 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010080104206 | NHSA |
| 山西津华晖星制药有限公司 | 国药准字H20050241 | 0.5g | Category B (乙) | XA10BAE021A010080902897 | NHSA |
| 山西津华晖星制药有限公司 | 国药准字H20050241 | 0.5g | Category B (乙) | XA10BAE021A010081002897 | NHSA |
| 山西津华晖星制药有限公司 | 国药准字H20050241 | 0.5g | Category B (乙) | XA10BAE021A010081102897 | NHSA |
| 山西津华晖星制药有限公司 | 国药准字H20050241 | 0.5g | Category B (乙) | XA10BAE021A010081202897 | NHSA |
| 山西津华晖星制药有限公司 | 国药准字H20050241 | 0.5g | Category B (乙) | XA10BAE021A010090102897 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010090104105 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010090104206 | NHSA |
| 山西津华晖星制药有限公司 | 国药准字H20050241 | 0.5g | Category B (乙) | XA10BAE021A010100102897 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010100104105 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010100104206 | NHSA |
| 山西津华晖星制药有限公司 | 国药准字H20050241 | 0.5g | Category B (乙) | XA10BAE021A010110102897 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010110104105 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010110104206 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010120104105 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010120104206 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010130104105 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010130104206 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H20051187 | 0.5g(以盐酸二甲双胍计) | Category B (乙) | XA10BAE021A010140104105 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010140104206 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010150104206 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010160104206 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010170104206 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010180104206 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010190104206 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010200104206 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010210104206 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010220104206 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010230104206 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20223796 | 0.5g | Category B (乙) | XA10BAE021A010240104206 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 10 filings and 8 distinct first applicants.
Supplement 4 · Generic 6
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 默克制药（江苏）有限公司 | CYHB2600003 | Supplement | 2026/01/05 | Not stated by source | CDE |
| 南京亿华药业有限公司 | CYHB2501167 | Supplement | 2025/06/12 | Not stated by source | CDE |
| 河北智恒医药科技股份有限公司;浙江京新药业股份有限公司 | CYHS2602344 | Generic | 2026/09/20 | Not stated by source | CDE |
| 石药集团欧意药业有限公司 | CYHB2601106 | Supplement | 2026/06/11 | Not stated by source | CDE |
| 哈尔滨同一堂药业有限公司 | CYHB2550358 | Supplement | 2025/11/08 | Not stated by source | CDE |
| 山东诚康药业有限公司;以岭万洲国际制药有限公司 | CYHS2503150 | Generic | 2025/08/28 | Not stated by source | CDE |
| 白云山东泰商丘药业有限公司 | CYHS2502809 | Generic | 2025/08/04 | Not stated by source | CDE |
| 河北新石制药有限公司;新石阳光药业（河北）有限公司 | CYHS2602694 | Generic | 2026/11/04 | Not stated by source | CDE |
| 河北新石制药有限公司;新石阳光药业（河北）有限公司 | CYHS2602693 | Generic | 2026/11/04 | Not stated by source | CDE |
| 河北新石制药有限公司;新石阳光药业（河北）有限公司 | CYHS2602692 | Generic | 2026/11/04 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 7 filings and 2 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 河北智恒医药科技股份有限公司;浙江京新药业股份有限公司 | CYHS2602344 | Generic | 2026/09/20 | Not stated by source | CDE |
| 河北新石制药有限公司;新石阳光药业（河北）有限公司 | CYHS2601250 | Generic | 2026/06/02 | Not stated by source | CDE |
| 河北新石制药有限公司;新石阳光药业（河北）有限公司 | CYHS2601249 | Generic | 2026/06/02 | Not stated by source | CDE |
| 河北新石制药有限公司;新石阳光药业（河北）有限公司 | CYHS2601248 | Generic | 2026/06/02 | Not stated by source | CDE |
| 河北新石制药有限公司;新石阳光药业（河北）有限公司 | CYHS2602694 | Generic | 2026/11/04 | Not stated by source | CDE |
| 河北新石制药有限公司;新石阳光药业（河北）有限公司 | CYHS2602693 | Generic | 2026/11/04 | Not stated by source | CDE |
| 河北新石制药有限公司;新石阳光药业（河北）有限公司 | CYHS2602692 | Generic | 2026/11/04 | Not stated by source | CDE |
API registrations
Non-component matches: 40 companies with A status and 3 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 盐酸二甲双胍 | 河南优凯制药有限公司 | Y20250000327 | A | Exact ingredient | 2026/11/04 | CDE |
| 盐酸二甲双胍 | 山东鲁瑞药业有限公司 | Y20250000352 | A | Exact ingredient | 2026/09/21 | CDE |
| 盐酸二甲双胍 | 白云山东泰商丘药业有限公司 | Y20240000805 | A | Exact ingredient | 2026/03/15 | CDE |
| 盐酸二甲双胍 | 莱阳司邦得制药有限公司 | Y20240000473 | A | Exact ingredient | 2025/12/12 | CDE |
| 盐酸二甲双胍 | 吉林凯莱英医药化学有限公司 | Y20240000113 | A | Exact ingredient | 2025/11/10 | CDE |
| 盐酸二甲双胍 | Sohan Healthcare Private Limited | Y20220000895 | A | Exact ingredient | 2026/01/22 | CDE |
| 盐酸二甲双胍 | 河北天成药业股份有限公司 | Y20220001156 | A | Exact ingredient | 2025/02/20 | CDE |
| 盐酸二甲双胍 | 江苏德源药业股份有限公司 | Y20220000686 | A | Exact ingredient | 2025/05/27 | CDE |
| 盐酸二甲双胍 | 华东医药（西安）博华制药有限公司 | Y20220000357 | A | Exact ingredient | 2024/05/13 | CDE |
| 盐酸二甲双胍 | IOL Chemicals and Pharmaceuticals Ltd. | Y20210000679 | A | Exact ingredient | 2024/02/18 | CDE |
| 盐酸二甲双胍 | SMRUTHI ORGANICS LIMITED | Y20200001011 | I | Exact ingredient | 2021/05/25 | CDE |
| 盐酸二甲双胍 | 天方药业有限公司 | Y20200001441 | A | Exact ingredient | 2022/08/31 | CDE |
| 盐酸二甲双胍 | 山东寿光博康制药有限公司 | Y20200001309 | A | Exact ingredient | 2024/06/14 | CDE |
| 盐酸二甲双胍 | HARMAN FINOCHEM LIMITED | Y20200001045 | A | Exact ingredient | 2024/11/21 | CDE |
| 盐酸二甲双胍 | Harman Finochem Limited | Y20200000973 | A | Exact ingredient | 2023/03/24 | CDE |
| 盐酸二甲双胍 | 宁夏恒康科技有限公司 | Y20200001044 | A | Exact ingredient | 2024/01/17 | CDE |
| 盐酸二甲双胍 | Abhilasha Pharma Pvt. Ltd. | Y20190021198 | A | Exact ingredient | 2022/10/31 | CDE |
| 盐酸二甲双胍 | Exemed Pharmaceuticals | Y20200000139 | A | Exact ingredient | 2022/11/07 | CDE |
| 盐酸二甲双胍 | Laurus Labs Limited | Y20200000513 | A | Exact ingredient | 2024/08/09 | CDE |
| 盐酸二甲双胍 | Apitoria Pharma Private Limited | Y20200000422 | A | Exact ingredient | 2025/04/10 | CDE |
| 盐酸二甲双胍 | Wanbury Limited | Y20200000314 | A | Exact ingredient | 2022/10/14 | CDE |
| 盐酸二甲双胍 | MERCK SANTE SAS | Y20190009925 | A | Exact ingredient | — | CDE |
| 盐酸二甲双胍 | 寿光富康制药有限公司 | Y20190009726 | A | Exact ingredient | 2026/01/24 | CDE |
| 盐酸二甲双胍 | 天津太平洋化学制药有限公司 | Y20190009517 | A | Exact ingredient | 2025/06/14 | CDE |
| 盐酸二甲双胍 | 山东科源制药股份有限公司 | Y20190009395 | A | Exact ingredient | 2026/07/07 | CDE |
| 盐酸二甲双胍 | Aarti Drugs Ltd. | Y20190009174 | A | Exact ingredient | 2025/08/06 | CDE |
| 盐酸二甲双胍 | 曲阜圣仁制药有限公司 | Y20190008915 | A | Exact ingredient | 2022/10/28 | CDE |
| 盐酸二甲双胍 | 石家庄市普力制药有限公司 | Y20190008451 | A | Exact ingredient | 2025/01/03 | CDE |
| 盐酸二甲双胍 | 江苏汉斯通药业有限公司 | Y20190007133 | A | Exact ingredient | — | CDE |
| 盐酸二甲双胍 | 淮南舜隆制药有限公司 | Y20190006466 | A | Exact ingredient | 2026/06/23 | CDE |
| 盐酸二甲双胍 | 华润双鹤药业股份有限公司 | Y20190006308 | A | Exact ingredient | 2023/03/24 | CDE |
| 盐酸二甲双胍 | 江苏同禾药业有限公司 | Y20190006246 | A | Exact ingredient | — | CDE |
| 盐酸二甲双胍 | 吉林金恒制药股份有限公司 | Y20190006023 | A | Exact ingredient | 2026/01/27 | CDE |
| 盐酸二甲双胍 | 好医生药业集团有限公司 | Y20190005982 | A | Exact ingredient | — | CDE |
| 盐酸二甲双胍 | 吉林省四合药业科技有限公司 | Y20190005512 | A | Exact ingredient | 2025/01/04 | CDE |
| 盐酸二甲双胍 | null | Y20190004800 | A | Exact ingredient | 2024/06/06 | CDE |
| 盐酸二甲双胍 | 富祥（大连）制药有限公司 | Y20190004140 | A | Exact ingredient | — | CDE |
| 盐酸二甲双胍 | 丹东医创药业有限责任公司 | Y20190003827 | A | Exact ingredient | 2025/06/07 | CDE |
| 盐酸二甲双胍 | 天津中新药业集团股份有限公司新新制药厂 | Y20190002946 | A | Exact ingredient | 2023/03/24 | CDE |
| 盐酸二甲双胍 | null | Y20190002602 | A | Exact ingredient | 2024/10/24 | CDE |
| 盐酸二甲双胍 | FARMHISPANIA, S.A. | Y20190000147 | I | Exact ingredient | 2019/09/27 | CDE |
| 盐酸二甲双胍 | Vistin Pharma AS | Y20190000108 | A | Exact ingredient | 2026/09/24 | CDE |
| 盐酸二甲双胍 | MERCK SANTE S.A.S. | Y20180001691 | A | Exact ingredient | 2026/03/20 | CDE |
| 盐酸二甲双胍 | 天津太平洋化学制药有限公司 | Y20180000014 | I | Exact ingredient | 2018/10/22 | CDE |
| 盐酸二甲双胍 | 山东科源制药股份有限公司 | Y20180000016 | A | Exact ingredient | 2023/08/14 | CDE |
| 盐酸二甲双胍 | 寿光富康制药有限公司 | Y20180000778 | A | Exact ingredient | — | CDE |
| 盐酸二甲双胍 | MERCK SANTE SAS | Y20170002070 | A | Exact ingredient | 2024/11/17 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/10 07:23. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
-
2026/11/06No longer listed under review
MERCK SERONO LIMITED;MERCK HEALTHCARE KGAA;Merck Serono Co. Ltd.
JYHZ2600138
Fact date: 2026/11/06 · Site observation date: 2026/11/06
Accepted: 2026/06/08
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ -
2026/11/04Approval-document delivery record
默克雪兰诺有限公司
JYHZ2600138 · 国药准字HJ20170029,国药准字HJ20170030
Fact date: 2026/11/04 · Publication date: 2026/11/06 · Site observation date: 2026/11/06
View source · Table row 197 ↗ -
2026/11/04Accepted
河北新石制药有限公司;新石阳光药业（河北）有限公司
CYHS2602694
Fact date: 2026/11/04 · Site observation date: 2026/11/05
View source ↗ -
2026/11/04Accepted
河北新石制药有限公司;新石阳光药业（河北）有限公司
CYHS2602693
Fact date: 2026/11/04 · Site observation date: 2026/11/05
View source ↗ -
2026/11/04Accepted
河北新石制药有限公司;新石阳光药业（河北）有限公司
CYHS2602692
Fact date: 2026/11/04 · Site observation date: 2026/11/05
View source ↗ -
2026/10/28No longer listed under review
重庆星创医药有限公司;植恩生物技术股份有限公司
CYHB2601858
Fact date: 2026/10/28 · Site observation date: 2026/10/28
Accepted: 2026/10/10
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/10/28 (approval no.: —; approval date: 2026/10/26); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 9
NMPA · Table row 9 ↗ View source ↗ -
2026/10/26Supplement delivery
重庆星创医药有限公司
CYHB2601858
Fact date: 2026/10/26 · Publication date: 2026/10/28 · Site observation date: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 9 ↗ -
2026/10/10Accepted
重庆星创医药有限公司;植恩生物技术股份有限公司
CYHB2601858
Fact date: 2026/10/10 · Site observation date: 2026/10/22
View source ↗ -
2026/09/20Accepted
河北智恒医药科技股份有限公司;浙江京新药业股份有限公司
CYHS2602344
Fact date: 2026/09/20 · Site observation date: 2026/10/22
View source ↗
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/10 07:27
- Chemical-drug catalogue
- Last successful update: 2026/11/10 07:23
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/10 07:25
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31
First index-page publication dates: 2026-10-26 to 2026-11-10; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/10 08:10 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 3/30; discovered pending details: 20. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Metformin Hydrochloride Extended-release Tablets
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Yearly
US$1,920
Billed every year
US$160 per month
Online subscriptions are not enabled. The form below registers interest; it does not charge or activate access.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
US$490
One payment · 12 months of access
Online comparison-table purchase is not enabled.
Billed by Creem, our merchant of record · Terms · Refund policy